[{"from": "human", "value": "Provide a brief overview of this molecule. [C][C][C][N][C][C][C][Branch1][Branch1][C][C][Ring1][=Branch1][C][=C][C][=Branch1][=Branch1][=C][C][=C][Ring1][=Branch1][S][=Branch1][C][=O][=Branch1][C][=O][C]"}, {"from": "gpt", "value": "The molecule is under investigation by NeuroSearch. ACR16 has been successfully investigated in a Phase II multi-centre, randomised and placebo-controlled trial in patients with Huntington\u2019s disease as well as in three Phase Ib studies within Huntington\u2019s disease, Parkinson\u2019s disease and schizophrenia respectively. ACR-16 is a dopamine stabilizer. ACR-16 is also being studied in other psychiatric and neurologic diseases."}]